Mufg Americas Holdings Corp Concert Pharmaceuticals, Inc. Transaction History

Mufg Americas Holdings Corp

  • $0
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 08, 2018
SELL
$13.96 - $29.05 $2,596 - $5,403
-186 Reduced 72.94%
69 $0
Q3 2017

Nov 13, 2017
SELL
$13.91 - $15.31 $2,295 - $2,526
-165 Reduced 39.29%
255 $0
Q2 2017

Aug 07, 2017
BUY
N/A
420
420 $0

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Mufg Americas Holdings Corp Portfolio

Follow Mufg Americas Holdings Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email